Protalix BioTherapeutics (PLX) Gets Huge Opportunity Due To Genzyme's (GENZ) Plant Shut-Down
Go back to Protalix BioTherapeutics (PLX) Gets Huge Opportunity Due To Genzyme's (GENZ) Plant Shut-Down| GENZYME (NASDAQ: GENZ) | Delayed: 40.35 +0.74 (1.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $39.61 | 52 Week High | $76.48 | |||
| Open | $40.35 | 52 Week Low | $65.50 | |||
| Day High | $40.35 | P/E | 336.25 | |||
| Day Low | $40.30 | EPS | $0.12 | |||
| Volume | 707 | |||||
| PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) | Delayed: 2.38 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.38 | 52 Week High | $1.11 | |||
| Open | $2.39 | 52 Week Low | $0.41 | |||
| Day High | $2.44 | P/E | N/A | |||
| Day Low | $2.35 | EPS | $-0.29 | |||
| Volume | 648,550 | |||||

